HOME >> BIOLOGY >> NEWS
Impressive new Impact Factors for BioMed Central's open-access journals

Eleven journals published by BioMed Central, the open access publisher, received their first Impact Factor this month. With nine journals in the top 10 of their 2005 Journal Citation Report* category, and ten journals with a 2005 Impact Factor exceeding 3.00, open access journals are confirmed as publishing high-quality, highly cited research.

Genome Biology, BioMed Central's flagship title covering biology in the post-genomic era, has been assessed as having an Impact Factor of 9.71. The journal's first Impact Factor places it in the top five of research journals in the highly competitive Genetics and Heredity field, and the 4th most cited journal in the Biotechnology & Applied Microbiology. Matthew Cockerill, BioMed Central's Publisher, comments, "Genome Biology's impressive Impact Factor is evidence of BioMed Central's commitment to quality, and shows that top researchers at the cutting edge of biology are increasingly choosing open access publication for their best work."

Malaria Journal, with a first Impact Factor of 2.14, is the number two journal in the Tropical Medicine field, and number five in the Parasitology category. Launched in 2001, Malaria Journal was one of the first journals started as part of BioMed Central's independent journal program, and is the first of these independent journals to receive an Impact Factor.

Seven journals in the BMC series also received their first Impact Factors this year. BMC Developmental Biology, with an Impact Factor of 5.41, is ranked at number six in the developmental biology field. BMC Structural Biology enters the Biophysics category at number eight, with an Impact Factor of 5.00. BMC Evolutionary Biology's Impact Factor of 4.45 is the 6th most highly cited journal in the evolutionary biology category. BMC Biotechnology now has an Impact Factor of 3.05, BMC Neuroscience 2.73, BMC Microbiology 2.18, BMC Gastroenterology 1.46.

Dr Cockerill continues, "These impressive rankings demonstrat
'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-207-631-9988
BioMed Central
20-Jun-2006


Page: 1 2

Related biology news :

1. Impact of forest certification in developing countries examined
2. Genome Biologys first Impact Factor 9.71
3. Factors affecting kernel yield in maize
4. BioMed Central announces new interdisciplinary Biofuels Journal
5. BioMed Central announces winners of first open access research awards
6. BioMed Central launches BMC Systems Biology, a new open access journal
7. BioMed Central launches Biology Direct
8. BioMed Central applauds Wellcomes leadership on Open Access
9. BioMed Central welcomes the new National Institutes of Health public access policy
10. BioMed Central announces publishing partnership with The Scientist magazine
11. Public Library of Science announces PLoS ONE: A new approach to open-access publishing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... , June 23, 2016 ... research report to its pharmaceuticals section with historic ... details and much more. Complete report ... 151 pages, profiling 15 companies and supported with ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global ...
Breaking Biology Technology:
Cached News: